Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Propagating Humanized BLT Mice for the Study of Human Immunology and Immunotherapy.

Smith DJ, Lin LJ, Moon H, Pham AT, Wang X, Liu S, Ji S, Rezek V, Shimizu S, Ruiz M, Lam J, Janzen DM, Memarzadeh S, Kohn DB, Zack JA, Kitchen SG, An DS, Yang L.

Stem Cells Dev. 2016 Dec 15;25(24):1863-1873. Epub 2016 Oct 18.

2.

A Designed Inhibitor of p53 Aggregation Rescues p53 Tumor Suppression in Ovarian Carcinomas.

Soragni A, Janzen DM, Johnson LM, Lindgren AG, Thai-Quynh Nguyen A, Tiourin E, Soriaga AB, Lu J, Jiang L, Faull KF, Pellegrini M, Memarzadeh S, Eisenberg DS.

Cancer Cell. 2016 Jan 11;29(1):90-103. doi: 10.1016/j.ccell.2015.12.002. Epub 2015 Dec 31.

3.

Tubal Ligation Induces Quiescence in the Epithelia of the Fallopian Tube Fimbria.

Tiourin E, Velasco VS, Rosales MA, Sullivan PS, Janzen DM, Memarzadeh S.

Reprod Sci. 2015 Oct;22(10):1262-71. doi: 10.1177/1933719115574345. Epub 2015 Mar 2.

4.

Low levels of circulating estrogen sensitize PTEN-null endometrial tumors to PARP inhibition in vivo.

Janzen DM, Paik DY, Rosales MA, Yep B, Cheng D, Witte ON, Kayadibi H, Ryan CM, Jung ME, Faull K, Memarzadeh S.

Mol Cancer Ther. 2013 Dec;12(12):2917-28. doi: 10.1158/1535-7163.MCT-13-0572. Epub 2013 Nov 12.

5.

Progesterone receptor signaling in the microenvironment of endometrial cancer influences its response to hormonal therapy.

Janzen DM, Rosales MA, Paik DY, Lee DS, Smith DA, Witte ON, Iruela-Arispe ML, Memarzadeh S.

Cancer Res. 2013 Aug 1;73(15):4697-710. doi: 10.1158/0008-5472.CAN-13-0930. Epub 2013 Jun 6.

6.

Estrogen and progesterone together expand murine endometrial epithelial progenitor cells.

Janzen DM, Cheng D, Schafenacker AM, Paik DY, Goldstein AS, Witte ON, Jaroszewicz A, Pellegrini M, Memarzadeh S.

Stem Cells. 2013 Apr;31(4):808-22. doi: 10.1002/stem.1337.

7.

Stem-like epithelial cells are concentrated in the distal end of the fallopian tube: a site for injury and serous cancer initiation.

Paik DY, Janzen DM, Schafenacker AM, Velasco VS, Shung MS, Cheng D, Huang J, Witte ON, Memarzadeh S.

Stem Cells. 2012 Nov;30(11):2487-97. doi: 10.1002/stem.1207.

8.

Collaboration of Kras and androgen receptor signaling stimulates EZH2 expression and tumor-propagating cells in prostate cancer.

Cai H, Memarzadeh S, Stoyanova T, Beharry Z, Kraft AS, Witte ON.

Cancer Res. 2012 Sep 15;72(18):4672-81. Epub 2012 Jul 17.

9.

Role of autonomous androgen receptor signaling in prostate cancer initiation is dichotomous and depends on the oncogenic signal.

Memarzadeh S, Cai H, Janzen DM, Xin L, Lukacs R, Riedinger M, Zong Y, DeGendt K, Verhoeven G, Huang J, Witte ON.

Proc Natl Acad Sci U S A. 2011 May 10;108(19):7962-7. doi: 10.1073/pnas.1105243108. Epub 2011 Apr 25.

10.

Differential transformation capacity of Src family kinases during the initiation of prostate cancer.

Cai H, Smith DA, Memarzadeh S, Lowell CA, Cooper JA, Witte ON.

Proc Natl Acad Sci U S A. 2011 Apr 19;108(16):6579-84. doi: 10.1073/pnas.1103904108. Epub 2011 Apr 4.

11.

Bmi-1 is a crucial regulator of prostate stem cell self-renewal and malignant transformation.

Lukacs RU, Memarzadeh S, Wu H, Witte ON.

Cell Stem Cell. 2010 Dec 3;7(6):682-93. doi: 10.1016/j.stem.2010.11.013.

12.

Cell-autonomous activation of the PI3-kinase pathway initiates endometrial cancer from adult uterine epithelium.

Memarzadeh S, Zong Y, Janzen DM, Goldstein AS, Cheng D, Kurita T, Schafenacker AM, Huang J, Witte ON.

Proc Natl Acad Sci U S A. 2010 Oct 5;107(40):17298-303. doi: 10.1073/pnas.1012548107. Epub 2010 Sep 20.

13.

Basal epithelial stem cells are efficient targets for prostate cancer initiation.

Lawson DA, Zong Y, Memarzadeh S, Xin L, Huang J, Witte ON.

Proc Natl Acad Sci U S A. 2010 Feb 9;107(6):2610-5. doi: 10.1073/pnas.0913873107. Epub 2010 Jan 25.

14.

Non-Peutz-Jeghers syndrome associated ovarian sex cord tumor with annular tubules: a case report.

Nosov V, Park S, Rao J, Memarzadeh S.

Fertil Steril. 2009 Oct;92(4):1497.e5-8. doi: 10.1016/j.fertnstert.2009.07.1002. Epub 2009 Aug 22.

PMID:
19703688
15.

Enhanced paracrine FGF10 expression promotes formation of multifocal prostate adenocarcinoma and an increase in epithelial androgen receptor.

Memarzadeh S, Xin L, Mulholland DJ, Mansukhani A, Wu H, Teitell MA, Witte ON.

Cancer Cell. 2007 Dec;12(6):572-85.

16.

Lymphovascular and perineural invasion in the parametria: a prognostic factor for early-stage cervical cancer.

Memarzadeh S, Natarajan S, Dandade DP, Ostrzega N, Saber PA, Busuttil A, Lentz SE, Berek JS.

Obstet Gynecol. 2003 Sep;102(3):612-9.

PMID:
12962952
17.

Expression of colony-stimulating factor 1 receptor during prostate development and prostate cancer progression.

Ide H, Seligson DB, Memarzadeh S, Xin L, Horvath S, Dubey P, Flick MB, Kacinski BM, Palotie A, Witte ON.

Proc Natl Acad Sci U S A. 2002 Oct 29;99(22):14404-9. Epub 2002 Oct 15.

18.

Urokinase plasminogen activator receptor: Prognostic biomarker for endometrial cancer.

Memarzadeh S, Kozak KR, Chang L, Natarajan S, Shintaku P, Reddy ST, Farias-Eisner R.

Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10647-52. Epub 2002 Jul 18. Erratum in: Proc Natl Acad Sci U S A 2002 Sep 17;99(19):12501. Memarzedeh Sanaz [corrected to Memarzadeh Sanaz].

Supplemental Content

Loading ...
Support Center